Eupraxia Pharmaceuticals Inc. (EPRX.TO) TSX
9.25
-0.32(-3.34%)
Currency In CAD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 412.35M |
| Enterprise Value | 332.08M |
| P/E Ratio | -8.98 |
| PEG Ratio | 0.23 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.75 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.11 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.29 |
| Return On Equity | -0.51 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -241,878 |
| EBITDA | -38.86M |
| Net Income | -39.25M |
| Diluted EPS | -1.05 |
Balance Sheet
| Total Cash | 138.98M |
| Total Cash/Share | 2.45 |
| Total Debt | 2.01M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 19.3 |
| Book Value Per Share | 2.4 |
Price History
| 52-Week Change | 71.93 |
| 52-Week High | 12.86 |
| 52-Week Low | 5.2 |
| Moving Average 50 Days | 9.87 |
| Moving Average 200 Days | 9.48 |
Statistics
| Average Volume | 60,390 |
| Shares Outstanding | 35.94M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
